References
- Jih MH, Kimyai Asadi A, Freedberg IM. Exfoliative dermatitis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Kastz SI, eds. Fitzpatrick’s dermatology in general medicine. 6th ed. New York: McGraw-Hill; 2003:436–439
- Sehgal VN, Srivastava G. Exfoliative dermatitis: a prospective study of 80 patients. Dermatologica 1986;173:278–284
- Yuan XY, Guo JY, Dang YP, et al. Erythroderma: a clinical–etiological study of 82 cases. Eur J Dermatol 2010;20:373–377
- Rothe MJ, Bernstein ML, Grant-Kels JM. Life-threatening erythroderma: diagnosing and treating the “red man”. Clin Dermatol 2005;23:206–207
- Sehgal VN, Srivastava G, Sardana K. Erythroderma/exfoliative dermatitis: a synopsis. Int J Dermatol 2004;43:39–47
- Holmes B, Heel RC, Brogden RN, et al. Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus. Drugs 1984;27:301–327
- Kilo C, Dudley J, Kalb B. Evaluation of the efficacy and safety of Diamicron in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 1991;14:79–82
- Aquino MR, Sher J, Fonacier L. Patch testing for drugs. Dermatitis 2013;24:205–214
- Jachiet M, Bellon N, Assier H, et al. Cutaneous adverse drug reaction to oral acetazolamide and skin tests. Dermatology 2013;226:347--352
- Ozmen S, Murat Ş, Yöney A, et al. Cutaneous drug eruptions in children; single centre experience. Turk Arch Ped 2011;46:63–67